BIOINVENT FINANS AB
556605-9571ActiveClinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- 2001
- Perustettu
Avainpäättäjät
Cecilia Hofvander
VP Investor Relations
Ashley Robinson
Senior Vice President Strategy & Finance
Bernd Seizinger
Chairman of the R&D Committee, Board Member
Stefan Ericsson
Chief Financial Officer
+19 lisää yhteystietoja Funnelfeedrissä
Kuvaus
BioInvent International AB is a clinical-stage company focused on discovering and developing novel antibody therapeutics for cancer treatment. The core of their work lies in immuno-oncology, leveraging deep expertise in immunology, cancer biology, and antibody biology. They utilize their proprietary...
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556605957101
Päättäjät
23 yhteystietoa FunnelfeedrissäCecilia Hofvander
VP Investor Relations
Ashley Robinson
Senior Vice President Strategy & Finance
Bernd Seizinger
Chairman of the R&D Committee, Board Member
Stefan Ericsson
Chief Financial Officer
Thomas Hecht
Chairman of the Remuneration Committee, Board Member
Kristoffer Bissessar
Chairman of the Audit Committee, Board Member
Tomas Wall
Employee Representative, Board Member
Natalie Berner
Member of the Board
Andres McAllister
Chief Medical Officer
Elin Birgersson
Employee Representative, Board Member
Leonard Kruimer
Chairman of the Board
Kristoffer Rudenholm Hansson
Senior Vice President, Technical Operations
Martin Welschof
Chief Executive Officer
Sylvie Ryckebusch
Chief Business Officer
Laura Lassouw-Polman
Member of the Board
Vincent Ossipow
Member of the Board
Nanna Lüneborg
Member of the Board
Björn Frendéus
Chief Scientific Officer
Anette Mårtensson
Employee Deputy, Board Member
Marina Mangold
Data Protection Officer
Ingunn Munch Lindvig
Senior Vice President Regulatory Affairs
Emma Meurling
HR Director
Muut yhteyshenkilöt
Kristoffer Rudenholm Hansson
Manufacturing Contact
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäAlligator Bioscience AB
10–19 työntekijätClinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
CAEDO ONCOLOGY AS
Developing novel monoclonal antibodies for targeted cancer immunotherapy treatment.
Active Biotech AB (publ)
1–4 työntekijätDeveloping novel treatments for cancer and inflammatory eye diseases.
Affibody AB
50–99 työntekijätDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Lead Biologics International AB
1–4 työntekijätExpert-led life science company developing novel antibody therapeutics for cancer.
Kysymyksiä yrityksestä BIOINVENT FINANS AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo